Related Experiment Video
Updated: Nov 1, 2025

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Timing of procedural interventions in childhood renovascular hypertension
Zubin J Modi1,2, David B Kershaw3
1Division of Pediatric Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA. modiz@med.umich.edu.
Insights
Renovascular hypertension (RVHTN) in children requires careful management. Optimal timing for procedural intervention balances patient factors, blood pressure control, and potential risks, often on a case-by-case basis.
Area of Science:
- Pediatric Nephrology
- Cardiovascular Medicine
- Interventional Radiology
Background:
- Renovascular hypertension (RVHTN) is a rare condition with diverse causes like fibromuscular dysplasia.
- Managing pediatric RVHTN involves complex decisions regarding medication and intervention timing.
- Limited evidence exists for optimal non-medical intervention timing in pediatric RVHTN.
Purpose of the Study:
- To present a case study on managing RVHTN in a 1-month-old infant.
- To highlight factors influencing the timing of interventions for pediatric RVHTN.
- To discuss the balance between conservative management and surgical intervention.
Main Methods:
- Case presentation of a 1-month-old infant with RVHTN.
- Conservative medical management initially.
- Consideration of surgical intervention due to concerns for renal growth.
Main Results:
- Initial conservative management was employed.
- Concerns for poor renal growth prompted re-evaluation.
- Surgical intervention was deemed feasible and safe.
Conclusions:
- Pediatric RVHTN management requires individualized treatment plans.
- Key considerations include patient age, size, disease severity, and comorbidities.
- Intervention timing should balance medical management, growth, and cardiac health, considering center expertise and family preferences.
Background:
Renovascular hypertension (RVHTN) is a rare, often complex condition due to multiple etiologies including congenital stenoses, vasculitides, and fibromuscular dysplasia. Among children with RVHTN who require multiple and escalating medications to control blood pressure, the optimal timing of a procedural intervention involves a balance of numerous factors.
Case-Diagnosis/Treatment:
In this presentation of a 1-month-old girl with RVHTN, the treating medical team had to consider multiple factors in the initial management and timing of interventions to treat her underlying cause of RVHTN, including concerns for kidney health, degree of hypertension, age and size of the patient, and potential methods of procedural intervention. Initially, she was treated conservatively until concern for poor renal growth arose and a durable surgical intervention was thought feasible and safe.
Conclusion:
The evidence regarding the timing of non-medical interventions in pediatric RVHTN is limited. Considerations should include patient age, size, disease severity, comorbid conditions, and degree of medical management required to maintain safe blood pressures that allow for growth and reverse cardiac damage. The optimal interventions have not been evaluated by controlled trials and should be decided on a case-by-case basis with consideration of center expertise and family preferences.
Related Concept Videos
Pre-Procedural Guidelines for Assessing Blood Pressure
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation III: Medical Management

